These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16450813)

  • 1. Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices.
    Naccarelli GV
    Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I51-7. PubMed ID: 16450813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
    Fazal IA; Bates MG; Matthews IG; Turley AJ
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction.
    Kadish AH; Reiffel JA; Naccarelli GV; DiMarco JP
    Am J Cardiol; 2008 Sep; 102(5A):29G-37G. PubMed ID: 18722189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators: a new preventive medical option.
    Glatter KA; Young JN; McElvany MD
    Prev Cardiol; 2006; 9(1):49-53; quiz 54-5. PubMed ID: 16407703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network.
    Greenlee RT; Go AS; Peterson PN; Cassidy-Bushrow AE; Gaber C; Garcia-Montilla R; Glenn KA; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Kadish A; Magid DJ; McManus DD; Multerer D; Powers JD; Reifler LM; Reynolds K; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Masoudi FA
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
    Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
    Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.
    McAlister FA; Ezekowitz J; Dryden DM; Hooton N; Vandermeer B; Friesen C; Spooner C; Rowe BH
    Evid Rep Technol Assess (Full Rep); 2007 Jun; (152):1-199. PubMed ID: 17764218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure.
    Woo CY; Strandberg EJ; Schmiegelow MD; Pitt AL; Hlatky MA; Owens DK; Goldhaber-Fiebert JD
    Ann Intern Med; 2015 Sep; 163(6):417-26. PubMed ID: 26301323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.
    Boriani G; Botto G; Lunati M; Proclemer A; Schmidt B; Erdogan A; Rauhe W; Biffi M; Santi E; Becker D; Messier M; Santini M
    BMC Cardiovasc Disord; 2012 Sep; 12():72. PubMed ID: 22966862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
    JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients.
    Ruskin JN; Camm AJ; Zipes DP; Hallstrom AP; McGrory-Usset ME
    J Cardiovasc Electrophysiol; 2002 Jan; 13(1):38-43. PubMed ID: 11843481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of implantable cardioverter-defibrillator device implants in the United States.
    Yousuf OK; Kennedy K; Russo A; Varosy P; Lindsay BD; Steinberg B; Atwater BD; Calkins H; Spertus JA
    Heart Rhythm; 2024 Apr; 21(4):397-407. PubMed ID: 38123044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.